Warfarin treatment
Dental extraction in patients on warfarin treatment
5
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
6
Effect of Standardized Warfarin Treatment Protocol on Anticoagulant Effect: Comparison of a Warfarin Medication Therapy Adherence Clinic with Usual Medical Care
9
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
10
Adherence to treatment guidelines: the association between stroke risk stratified comparing CHADS2 and CHA2DS2 VASc score levels and warfarin prescription for adult patients with atrial fibrillation
8
Patient satisfaction after switching from warfarin to apixaban in patients with nonvalvular atrial fibrillation: AGAIN study
10
<p>Validation and psychometric properties of the Maltese version of the Duke Anticoagulation Satisfaction Scale (DASS)</p>
12
Radix Puerariae lobatae (Gegen) suppresses the anticoagulation effect of warfarin: a pharmacokinetic and pharmacodynamics study
17
Pharmacogenetics in warfarin therapy
221
<p>Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats</p>
11
Estimation of plasma levels of warfarin and 7-hydroxy warfarin by high performance liquid chromatography in patients receiving warfarin therapy
5
“The Efficacy and Safety of Rivaroxaban as an Alternative to Warfarin for the Prevention of Thromboembolism in Patients with Atrial Fibrillation” by Rania Ibrahim Shoshaa, Osama Mohamed Ibrahim, Mohamed Elsaid Setiha, Amr abdelmonem abdelwahab, Egypt.
11
Monoclonal anti human factor VII antibodies Detection in plasma of a second protein antigenically and genetically related to factor VII
11
Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
8
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
8
Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular diseaseReport of the Guideline Development Subcommittee of the American Academy of Neurology
7
Warfarin Binding to Native and Structurally-Altered Human Serum Albumins
6
Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome
9
<p>Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia</p>
6
Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
7